169 related articles for article (PubMed ID: 28854773)
1. Bile Duct Patency Maintained after Intraductal Radiofrequency Ablation in a Case of Hepatocellular Cholangiocarcinoma with Bile Duct Invasion.
Han SY; Song GA; Kim DU; Baek DH; Lee MW; Kim GH
Clin Endosc; 2018 Mar; 51(2):201-205. PubMed ID: 28854773
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous endobiliary radiofrequency ablation and stents in management of hepatocellular carcinoma with bile duct tumor thrombus: Initial single-institution experience.
Cui W; Xu R; Wang Y; Shi F; Li J; Chen X
Asia Pac J Clin Oncol; 2020 Aug; 16(4):259-265. PubMed ID: 32368843
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Intraductal Radiofrequency Ablation for Extrahepatic Distal Cholangiocarcinoma: A Method for Prolonging Stent Patency and Achieving Better Functional Status and Quality of Life.
Wu TT; Li WM; Li HC; Ao GK; Zheng F; Lin H
Cardiovasc Intervent Radiol; 2017 Feb; 40(2):260-269. PubMed ID: 27743089
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic Therapy (PDT), Radiofrequency Ablation (RFA) With Biliary Stents in Palliative Treatment of Unresectable Extrahepatic Cholangiocarcinoma: A Systematic Review and Meta-analysis.
Mohan BP; Chandan S; Khan SR; Kassab LL; Ponnada S; Artifon ELA; Otoch JP; McDonough S; Adler DG
J Clin Gastroenterol; 2022 Feb; 56(2):e153-e160. PubMed ID: 33780214
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma.
Wang Y; Cui W; Fan W; Zhang Y; Yao W; Huang K; Li J
Oncotarget; 2016 Aug; 7(33):53911-53920. PubMed ID: 27322076
[TBL] [Abstract][Full Text] [Related]
6. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial.
Yang J; Wang J; Zhou H; Zhou Y; Wang Y; Jin H; Lou Q; Zhang X
Endoscopy; 2018 Aug; 50(8):751-760. PubMed ID: 29342492
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique.
Figueroa-Barojas P; Bakhru MR; Habib NA; Ellen K; Millman J; Jamal-Kabani A; Gaidhane M; Kahaleh M
J Oncol; 2013; 2013():910897. PubMed ID: 23690775
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for bile duct invasion of hepatocellular carcinoma.
Bahng S; Yoo BC; Paik SW; Koh KC; Lee KT; Lee JK; Lee JH; Choi MS; Lee KH
Photochem Photobiol Sci; 2013 Mar; 12(3):439-45. PubMed ID: 23175171
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous transhepatic cholangiography and intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction.
Li TF; Huang GH; Li Z; Hao CF; Ren JZ; Duan XH; Zhang K; Chen C; Han XW; Jiao DC; Zhang MF; Wang YL
J Vasc Interv Radiol; 2015 May; 26(5):715-21. PubMed ID: 25817458
[TBL] [Abstract][Full Text] [Related]
11. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction.
Steel AW; Postgate AJ; Khorsandi S; Nicholls J; Jiao L; Vlavianos P; Habib N; Westaby D
Gastrointest Endosc; 2011 Jan; 73(1):149-53. PubMed ID: 21184881
[TBL] [Abstract][Full Text] [Related]
12. Role of Intraductal RFA: A Novel Tool in the Palliative Care of Perihilar Cholangiocarcinoma.
Weismüller TJ
Visc Med; 2021 Feb; 37(1):39-47. PubMed ID: 33718482
[TBL] [Abstract][Full Text] [Related]
13. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study.
Laleman W; van der Merwe S; Verbeke L; Vanbeckevoort D; Aerts R; Prenen H; Van Cutsem E; Verslype C
Endoscopy; 2017 Oct; 49(10):977-982. PubMed ID: 28732391
[No Abstract] [Full Text] [Related]
14. The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience.
Cui W; Fan W; Lu M; Zhang Y; Yao W; Li J; Wang Y
BMC Cancer; 2017 Apr; 17(1):288. PubMed ID: 28438130
[TBL] [Abstract][Full Text] [Related]
15. Comparing palliative treatment options for cholangiocarcinoma: photodynamic therapy vs. radiofrequency ablation.
Mohammad T; Kahaleh M
Clin Endosc; 2022 May; 55(3):347-354. PubMed ID: 35578751
[TBL] [Abstract][Full Text] [Related]
16. Intraductal radiofrequency ablation of tumour ingrowth into an uncovered metal stent used for inoperable cholangiocarcinoma.
Lui KL; Li KK
Hong Kong Med J; 2013 Dec; 19(6):539-41. PubMed ID: 24310661
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice.
Shiryaev AA; Musaev GK; Levkin VV; Reshetov IV; Loshchenov MV; Alekseeva PM; Volkov VV; Linkov KG; Makarov VI; Shchekoturov IO; Borodkin AV; Loschenov VB
Photodiagnosis Photodyn Ther; 2019 Jun; 26():218-223. PubMed ID: 30965145
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction.
Cui W; Wang Y; Fan W; Lu M; Zhang Y; Yao W; Li J
Int J Hyperthermia; 2017 Nov; 33(7):853-861. PubMed ID: 28540797
[TBL] [Abstract][Full Text] [Related]
19. Intraductal Radiofrequency Ablation Followed by Locoregional Tumor Treatments for Treating Occluded Biliary Stents in Non-Resectable Malignant Biliary Obstruction: A Single-Institution Experience.
Duan XH; Wang YL; Han XW; Ren JZ; Li TF; Zhang JH; Zhang K; Chen PF
PLoS One; 2015; 10(8):e0134857. PubMed ID: 26244367
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction Caused by Recurrence and Metastasis after Primary Tumor Resection.
Cui W; Fan W; Lu M; Zhang Y; Yao W; Wang Y; Li J
Oncol Res Treat; 2018; 41(1-2):22-28. PubMed ID: 29393244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
